In a small trial of 14 patients, a CRISPR gene editing therapy improved vision among 11 participants, according to research led by a Mass General Brigham clinician. The phase 1/2 trial, sponsored by ...

The recent progress and future development of gene therapy could help patients with wet age-related macular degeneration maintain vision, according to a speaker at Retina 2026. Allen C. Ho, MD, of ...

The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

Continued clinical progress follows regulatory authorization to advance study First patient continues to show dramatic vision restoration GREENSBORO, N.C., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Precise ...

A tabletop device that delivers various wavelengths of light therapy to the back of the eye to activate cellular function in people with intermediate dry age-related macular degeneration (AMD) ...

CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...

Two Chairs, a hybrid behavioral health provider, has launched a data dashboard so patients can see insights into their therapy progress. My Care Journey builds on the company’s measurement-based care ...